Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Cynthia W Buness"'
Potential Association of Doxycycline With the Onset of Primary Sclerosing Cholangitis: A Case Series
Autor:
Kenneth L. Cox, Keith D. Lindor, Ahmad H. Ali, James Gage Buness, James H. Tabibian, Cynthia W Buness
Publikováno v:
American Journal of Therapeutics. 29:e437-e443
Background Primary sclerosing cholangitis (PSC) is linked to inflammatory bowel diseases (IBD). Evidence suggests an association between the gut microbiome and PSC. However, the putative relationship between exposure to antibiotics and onset of PSC h
Autor:
Ahmad H. Ali, Cynthia W. Buness, Ryan Fischer, Gerald J. Holtmann, Ayesha Shah, Peter Lewindon, Shamita Shah, Amol S. Ragnekar, Amy E. Taylor, Aparna Goel, Kenneth L. Cox, Leina Alrabadi, Steve Wadsworth, Sakil S. Kulkarni, Keith D. Lindor
Publikováno v:
Hepatology. 77:E174-E175
Autor:
Kevin M. Johnson, Kenneth L. Cox, Leina Alrabadi, Cynthia W Buness, Ahmad H. Ali, Tamir Miloh, Keith D. Lindor
Publikováno v:
Clinical Journal of Gastroenterology. 14:684-689
Primary sclerosing cholangitis (PSC) is a rare, progressive liver disease characterized by cholestasis and bile duct fibrosis that has no accepted therapy known to delay or arrest its progression. We report a 23-year-old female patient who at age 14
Autor:
Cynthia W, Buness, Kevin M, Johnson, Ahmad Hassan, Ali, Leina, Alrabadi, Keith D, Lindor, Tamir, Miloh, Kenneth L, Cox
Publikováno v:
Clinical journal of gastroenterology. 14(2)
Primary sclerosing cholangitis (PSC) is a rare, progressive liver disease characterized by cholestasis and bile duct fibrosis that has no accepted therapy known to delay or arrest its progression. We report a 23-year-old female patient who at age 14
Autor:
Cynthia W Buness, Kenneth L. Cox, Jennifer Damman, Elizabeth J. Carey, Yinka K. Davies, Melissa Hurwitz, Ahmad H. Ali, Leina Alrabadi, Mariam Stephen, Shamita B. Shah, Keith D. Lindor, Leta M. Lemos, William E. Berquist
Publikováno v:
Scandinavian journal of gastroenterology. 55(8)
Oral vancomycin (OV) in primary sclerosing cholangitis (PSC) has been evaluated as a potential therapeutic agent. We report the long-term biochemical course and outcomes of patients with PSC treated with OV.Patients were enrolled in 2 open-label clin
Oral Vancomycin Therapy in a Child with Primary Sclerosing Cholangitis and Severe Ulcerative Colitis
Publikováno v:
Pediatric Gastroenterology, Hepatology & Nutrition
Primary sclerosing cholangitis (PSC), a rare progressive liver disease characterized by cholestasis and bile duct fibrosis, has no accepted, effective therapy known to delay or arrest its progression. We report a 15 year old female patient diagnosed
Autor:
J. L. Damman, Cynthia W Buness, Eduardo A. Rodriguez, Kenneth L. Cox, Keith D. Lindor, Ahmad H. Ali, Elizabeth J. Carey
Publikováno v:
Alimentary pharmacologytherapeutics. 47(7)
Background and aims PSC is an autoimmune biliary inflammatory disorder that is often associated with inflammatory bowel disease (IBD), with 50%-75% of patients with PSC having coexisting IBD, most commonly ulcerative colitis. Currently, no medical th